IDXX vs WAT — Key Metrics
| Metric | IDXX (IDEXX LABORATORIES INC) | WAT (WATERS CORP) |
|---|---|---|
| Price | 698.47 | 466.1 |
| Market Cap | 55.03 Billion | 45.81 Billion |
| P/E (TTM) | 46.81 | 192.6 |
| P/B (Quarterly) | 28.31 | 3.056 |
| P/S (TTM) | 11.8 | 8.17 |
| Net Profit Margin (TTM) | 25.4 | 1.8 |
| Gross Margin (TTM) | 62.7 | 49.5 |
| ROE (TTM) | 71.2 | 0.8 |
| Revenue Growth YoY (TTM) | n/a | n/a |
Upfront Investment - S&P 500 Stock Comparison & AI Analysis
AI-powered analysis and comparison tools for S&P 500 stocks, helping investors make data-driven decisions with delayed market data and portfolio modeling.
Performance Comparison
AI Model Recommendation
Greatly Underperform
Greatly Underperform
Recommendation Summary
Both stocks are projected to greatly underperform the market over the next year. If you have to make a choice, Upfront Recommendation: WAT.
Financial Metrics
| IDXX | Metrics | WAT |
|---|---|---|
| $698.47 | Price | $466.10 |
| — | Market Capitalization | — |
| 46.81 | Price to Earnings Ratio | 192.6 |
| 11.8 | Price to Sales | 8.17 |
| 42.65 | Price to FCF Ratio | 156.13 |
| 18.82 | Price to Gross Profit | 16.49 |
| 206.21 | Price to R&D | 123.51 |
| 36.69 | Price to Current Assets | 11.11 |
IDXX vs WAT at a glance
Idexx Laboratories INC (IDXX) and Waters Corp (WAT) are both Diagnostics & Research companies in the Healthcare sector. IDXX is the larger, at $55.0 billion in market value against $45.8 billion for WAT, about 1.2 times the size.
On trailing-twelve-month figures, IDXX trades at 46.8 times trailing earnings and WAT at 192.6; net profit margins are 25.4% and 1.8%.
The Upfront Investment model currently rates both Greatly Underperform as of November 18, 2026. The rating ranks the model's medium-term return forecast against the other stocks it scores; it is a statistical forecast, not investment advice.